companies wanted
click here
Site Map
Search Site Content
Join Us
Contact Us
CBA News
User Login
Partner Login
Business Summary
Print Friendly, PDF & Email
Capital Raising

Natural antioxidant greenfield investment opportunity

Mandate ID: SE-7-MD-5-2303-3
Transaction Type:
Capital Raising

Industry: Biotech


Sector: Antioxidant production


SIC Code: 87310102 BIOTECHNICAL RESEARCH, COMMERCIAL


Country of Origin: Sweden | Sweden


Target Countries: Sweden


Target Areas: Worldwide


Capital Raising > Natural antioxidant greenfield investment opportunity

Business Review

Mandate to search for (preferable) one equity investor in a Nordic greenfield project. The project financing of USD 60 million is fully secured at favourable terms with a required USD 12 million as a collateral for the project financing.

An experienced and successful management team with a track record in same business aim to create a new world leader in the production of a fast growing and profitable antioxidant.

Exit envisaged through 1) 49% shareholding in the project with an expected IPO or trade sale in 7-8 years (IRR 33% in base case)
or 2) fixed repayment of USD 24 million after five years (IRR 15%).

Look forward to discuss potential greenfield investors with you. Client approval required before any external contacts.

Products

Antioxidant

Financial Information

Capital required: USD 12 million


Highlights

Investment highlights
• Fast growing food supplement/fish farming/pharmaceutical market (ca 15% CAGR) with strong market potential and various development opportunities;
• Multiple positive health effects, e.g. cognitive health, cardiovascular support, ocular health, skin, brain health, immune system, muscle support, anti-aging, athletic performance etc.;
• Perfect location for this type of product enabling a CO2 negative footprint and benchmark costs; opportunity to create a new leading global producer of a specific type of antioxidant;
• Fully secured project financing of USD 60 million with favorable terms subject to USD 12 million equity collateral;
• Highly profitable product with many attractive existing (health, food, beverage, cosmetics etc.) and new expected (pharmaceutical) application areas;
• Experienced management with successful operation track-record of establishing and managing same plants of industrial scale creates a competitive edge and barrier for new potential market entrants;
• Dynamic and rapidly developing food supplement/fish farming/pharmaceutical market - collaboration with food producers and pharmaceutical companies

Request More Information